Status:
COMPLETED
Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Human Immunodeficiency Virus
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalit...
Detailed Description
This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distr...
Eligibility Criteria
Inclusion
- 18-65 years old
- previous FRAM 1 participant
- HIV positive
Exclusion
- Artificial knee or hip replacement or Harrington rod
- Metal objects in the body.Pregnancy
- Breastfeeding or less than 3 months after breastfeeding
- Weight more than 300 pound
- On insulin, pancreatic enzymes, or thioridazine.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00244803
Start Date
January 1 2005
End Date
May 1 2007
Last Update
August 31 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University, The Clinical Trials Unit
Baltimore, Maryland, United States, 21205